Access cutting-edge glycogen storage disease treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access glycogen storage disease specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glycogen storage disease treatment provided free
The main goal of this trial is to evaluate the safety and tolerability of mRNA-3745 via intravenous (IV) administration in adult and pediatric participants with GSD1a.
Sponsor: ModernaTX, Inc.
Check if you qualify for this glycogen storage disease clinical trial in Boston, MA
If you're searching for glycogen storage disease treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glycogen storage disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.